Finance Minister Nirmala Sitharaman on Sunday announced a Rs 10,000 crore outlay for the Bio Pharma Shakti scheme for ...

Union Finance Minister Nirmala Sitharaman marked a major push to elevate India’s health sector with initiatives spanning ...

The Finance Minister has envisioned Biopharma SHAKTI (Strategy for Healthcare Advancement through Knowledge, Technology and Innovation) with an outlay of ₹ 10,000 crores over the next 5 years.

Finance Minister Nirmala Sitharaman, in her budget speech, unveiled “Biopharma Shakti”, a ₹10,000-crore strategy aimed at ...

Finance Minister Nirmala Sitharaman on Sunday announced the Rs 10,000 crore ‘BioPharma Shakti’ initiative in Budget 2026 to ...

Budget 2026 focuses on affordable healthcare with cheaper cancer medicines, a Rs 10K crore Biopharma SHAKTI mission, ...

One of the key highlights of Budget 2026 is the Biopharma Shakti initiative. The scheme is expected to boost India's ...

Union Budget 2026 unveiled a Rs 10,000 crore Biopharma Shakti mission to boost advanced medicine production, tackle rising diabetes and obesity, and strengthen India’s fight against non-communicable ...

Finance Minister Nirmala Sitharaman, during her ninth consecutive Budget speech, announced an outlay of ₹10,000 crore under ...

Pharma stocks experienced a significant surge after Finance Minister Nirmala Sitharaman announced the Rs 10,000 crore ...

The 2026 Budget emphasizes non-communicable diseases, elderly care, and bio-pharmaceutical manufacturing while offering tax waivers for certain drugs.

Finance Minister Nirmala Sitharaman announces Biopharma Shakti, a ₹10,000 crore plan to boost biologics, biosimilars, clinical trials and regulatory capacity in India.